KEVIN BLANCHARD: Open Payments
NPI 1205995065 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 20 payments from 10 companies in 2025. Trend: 2023 $1,206 · 2024 $990 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $113 |
| ABBVIE INC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $37 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Lilly USA, LLC | 1 | $24 |
| Alkermes, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: UBRELVY, Wegovy, AIRSUPRA, PAXLOVID, UNITHROID, MOUNJARO, VIVITROL, Ozempic.
Industry payments across MA — which companies pay providers there.
